Suppressor of cytokine signaling-1 attenuates the duration of interferon γ signal transduction in vitro and in vivo

被引:94
作者
Brysha, M
Zhang, JG
Bertolino, P
Corbin, JE
Alexander, WS
Nicola, NA
Hilton, DJ
Starr, R [1 ]
机构
[1] PO Royal Melbourne Hosp, Cooperat Res Ctr Cellular Growth Factors, Melbourne, Vic 3050, Australia
[2] PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia
[3] Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia
关键词
D O I
10.1074/jbc.M102737200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Suppressor of cytokine signaling-1 (SOCS-1) is a cytokine-inducible intracellular protein that functions to negatively regulate cytokine signal transduction pathways. Studies in vitro have shown that constitutive over expression of SOCS-1 inhibits signaling in response to a range of cytokines, including interferons (IFN). Mice lacking SOCS-1 die from a complex disease characterized by liver degeneration and massive inflammation. Whereas there is clear evidence of increased IFN gamma signaling in SOCS-1(-/-) mice, it is unclear to what extent this is due to increased IFN gamma levels or to increased IFN gamma sensitivity. Here we have used SOCS-1(-/-) IFN gamma (-/-) mice, which remain healthy and produce no endogenous IFN gamma to demonstrate that in vitro and in vivo hepatocytes lacking SOCS-1 exhibit a prolonged response to IFN gamma and that this correlates with a dramatically increased sensitivity to the toxic effects of IFN gamma in vivo. Thus, SOCS-1 is required for the timely attenuation of IFN gamma signaling in vivo.
引用
收藏
页码:22086 / 22089
页数:4
相关论文
共 31 条
[1]   Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling [J].
Adams, TE ;
Hansen, JA ;
Starr, R ;
Nicola, NA ;
Hilton, DJ ;
Billestrup, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) :1285-1287
[2]   SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine [J].
Alexander, WS ;
Starr, R ;
Fenner, JE ;
Scott, GL ;
Handman, E ;
Sprigg, NS ;
Corbin, JE ;
Cornish, AL ;
Darwiche, R ;
Owczarek, CM ;
Kay, TWH ;
Nicola, NA ;
Hertzog, PJ ;
Metcalf, D ;
Hilton, DJ .
CELL, 1999, 98 (05) :597-608
[3]  
Bertolino P, 1998, EUR J IMMUNOL, V28, P221, DOI 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.3.CO
[4]  
2-6
[5]   Cellular responses to interferon-gamma [J].
Boehm, U ;
Klamp, T ;
Groot, M ;
Howard, JC .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :749-795
[6]   RAPID ACTIVATION BY INTERFERON-ALPHA OF A LATENT DNA-BINDING PROTEIN PRESENT IN THE CYTOPLASM OF UNTREATED CELLS [J].
DALE, TC ;
IMAM, AMA ;
KERR, IM ;
STARK, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) :1203-1207
[7]  
DAMELL JE, 1994, SCIENCE, V264, P1415
[8]   Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease [J].
Durbin, JE ;
Hackenmiller, R ;
Simon, MC ;
Levy, DE .
CELL, 1996, 84 (03) :443-450
[9]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[10]  
GRESSER I, 1981, AM J PATHOL, V102, P396